Omega Therapeutics Inc. (OMGA)
undefined
undefined%
At close: undefined
0.97
-1.65%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 3.09M 2.07M 144.00K - -
Cost of Revenue 65.87M 5.19M 1.39M 1.15M 794.00K
Gross Profit -62.77M -3.12M -1.24M -1.15M -794.00K
Operating Income -100.26M -102.77M -66.03M -28.64M -17.34M
Interest Income 2.81M 222.00K 910.00K 777.00K 595.00K
Pretax Income -97.43M -102.70M -68.28M -29.45M -17.95M
Net Income -97.43M -102.64M -69.16M -30.20M -18.53M
Selling & General & Admin 26.19M 21.82M 16.60M 6.24M 4.23M
Research & Development 77.17M 80.00M 47.87M 21.06M 11.93M
Other Expenses - 3.02M 1.71M 1.35M 1.18M
Operating Expenses 103.36M 104.84M 66.18M 28.64M 17.34M
Interest Expense - 222.00K 910.00K 777.00K 595.00K
Selling & Marketing Expenses - - - - -
Cost & Expenses 103.36M 104.84M 66.18M 28.64M 17.34M
Income Tax - -65.00K 882.00K 752.00K 584.00K
Shares Outstanding (Basic) 54.01M 47.88M 47.79M 47.84M 47.84M
Shares Outstanding (Diluted) 54.01M 47.88M 47.79M 47.84M 47.84M
EPS (Basic) -1.8 -2.14 -1.45 -0.63 -0.39
EPS (Diluted) -1.8 -2.14 -1.45 -0.63 -0.39
EBITDA -93.49M -97.58M -64.64M -27.50M -16.55M
Depreciation & Amortization 6.77M 5.19M 1.39M 1.15M 794.00K